About The CJKHD
Canadian Journal of Kidney Health and Disease, the official journal of the Canadian Society of Nephrology, is an open access, peer-reviewed online journal that encourages high quality submissions focused on clinical, translational and health services delivery research in the field of chronic kidney disease, dialysis, kidney transplantation and organ donation.
Our mandate is to promote and advocate for kidney health as it impacts national and international communities.
Amogh
Agrawal
Amogh Agrawal, MD, FRCPC
Associate Editor
Dialysis (home dialysis, quality improvement)
Dr. Agrawal is a nephrologist and adjunct assistant clinical professor in the Department of Medicine, McMaster University. He completed his MD at the University of Calgary, training in Internal Medicine at the University of Alberta andNephrology at the University of Toronto. He pursued additional fellowships in Kidney Transplant at the Mayo Clinic in Rochester, Minnesota, and Home Dialysis at McMaster University. Now, he is working towards completing the Excellence in Quality Improvement Certificate Program through the University of Toronto’s Centre for Quality Improvement and Patient Safety, and has a particular interest in increasing the uptake of home dialysis modalities amongst patients with chronic kidney disease, especially those with unplanned and crash dialysis starts.
Aminu
Bello
Aminu Bello, MD, PhD, FRCPC, FACP, FASN
Associate Editor
Non-dialysis nephrology (CKD)
Dr Bello is a professor of medicine at the University of Alberta, and Consultant Nephrologist at the University of Alberta Hospital. He qualified as a medical doctor in Nigeria at Usmanu Danfodiyo University, Sokoto, and underwent specialist clinical training in internal medicine, nephrology, and epidemiology in Nigeria, UK and Canada. He holds research grants from major provincial and national research organizations including CIHR. He has published original research work in major general medical journals including the Lancet, JAMA and the BMJ. He reviews regularly for the major general medical and nephrology journals including The Lancet, JAMA, BMJ and Kidney International. He has more than 200 peer-reviewed scientific publications (articles, book chapters and monographs), and is keenly interested in global health initiatives to improve nephrology practice and education in emerging nations. He is currently a Co-Chair for the International Society of Nephrology (ISN) Global Kidney Health Atlas (GKHA) Project; an initiative for the development and implementation of strategies to enhance global equity in kidney care across all regions and countries of the world.
Clara
Bohm
Clara Bohm, MD, FRCPC, MPH
Associate Editor
Dialysis
Qualitative Research/Mixed Methods (exercise and physical activity in all stages of CKD, POR)
Dr. Bohm is an associate professor of internal medicine at the University of Manitoba and a nephrologist in the Manitoba Renal Program. She is cross-appointed to the Department of Community Health Sciences and a research affiliate with the Health, Leisure and Human Performance Institute, Faculty of Kinesiology and Recreation Management, University of Manitoba. Her clinical and research interests focus on improving quality of life in people on dialysis. She leads the Can-SOLVE CKD Triple I Project, striving to identify challenges and develop solutions to improve patient-centred care in hemodialysis. She also leads several nationally funded clinical trials that aim to characterize the effect of exercise on symptom burden and functional status in individuals on hemodialysis. As an "early adopter" of patient engagement, Dr. Bohm works to highlight and incorporate the perspectives of individuals with kidney disease in all her clinical and research endeavours.
Darren
Bridgewater
Darren Bridgewater, PhD
Associate Editor
Basic Science (kidney organogenesis)
Dr. Bridgewater is an associate professor in the Department of Pathology and Molecular Medicine at McMaster University. Dr. Bridgewater obtained his PhD in the Department of Anatomy and Cell Biology at the University of Western Ontario, and completed his post-doctoral fellowship in Developmental Biology at the Hospital For Sick Children, University of Toronto. Congenital anomalies of the kidney and urinary tract (CAKUT) comprise a pleitrophic group of developmental anomalies arising from a fundamental failure in normal kidney development, and constitute the major cause of childhood renal failure. Dr. Bridgewater research focusses on elucidating the fundamental molecular mechanisms underlying normal kidney development to advance our understanding of mechanisms that lead to disease. Dr. Bridgewater’s research is funded by Kidney Foundation of Canada, NSERC and CIHR.
Dylan
Burger
Dylan Burger, PhD, ISHF
Associate Editor
Basic Science (cell biology)
Hypertension
Dr. Burger is a senior scientist at the Ottawa Hospital Research Institute and Associate Professor at the University of Ottawa (Department of Cellular and Molecular Medicine). He holds a PhD in Physiology and Pharmacology from the University of Western Ontario and completed post-doctoral studies with Drs. Rhian Touyz and Kevin Burns at the Ottawa Hospital Research Institute. His independent research program focuses on understanding the molecular underpinnings of diabetes and hypertension and their associated renal complications. In particularly he has been active in the study of extracellular vesicles as markers and mediators of vascular and renal injury for more than 10 years. He has authored more than 100 manuscripts and has received several awards including the 2016 Canadian Society of Nephrology New Investigator Lectureship and the 2018 University of Ottawa Department of Medicine PhD Scientist Award. Dr. Burger was also the recipient of a 2014 New Investigator Award from the KRESCENT program (kidney research scientist core education and national training program) which is a joint initiative through the Kidney Foundation of Canada, Canadian Society of Nephrology and the Canadian Institute of Health Research.
He is the current chair of Communications for the International Society of Hypertension. Dr. Burger is a founding member of The Lancet Commission on Hypertension and associate editor for the European Heart Journal and the Journal of Extracellular Vesicles. He was co-chair of the first Molecules and Mechanisms Mediating Kidney Health and Disease Symposium in 2021.
Mark
Canney
Mark Canney, MD, PhD, FRCPC
Associate Editor
Non-dialysis nephrology (CKD, GN)
Dr. Mark Canney is an assistant professor in the Department of Medicine at the University of Ottawa, associate scientist at the Ottawa Hospital Research Institute, and staff nephrologist at the Ottawa Hospital. He completed his undergraduate medical degree at National University of Ireland Galway and undertook his internal medicine and nephrology training in Ireland. He completed a PhD in population health epidemiology at Trinity College Dublin in 2017 before moving to Canada to pursue a post-doctoral research fellowship at the University of British Columbia under the mentorship of Dr. Adeera Levin and Dr. Sean Barbour. It was there that he cultivated his research interests in the epidemiology of glomerular disease and refining our understanding of clinical outcomes in patients with different types of kidney disease. With the support of the KRESCENT program, Dr. Canney seeks to improve the awareness, assessment and management of cardiovascular risk among patients with glomerular disease.
Wisit
Cheungpasitporn
Wisit Cheungpasitporn
Associate Editor
AI Methodologies
Epidemiology
Wisit Cheungpasitporn, MD, FACP, FASN, FAST, is a Professor of Medicine at the Mayo Clinic College of Medicine and Science and a consultant in the Division of Nephrology and Hypertension at Mayo Clinic in Rochester, Minnesota. He also serves as the Artificial Intelligence Content Lead and Course Director at the Mayo Clinic Alix School of Medicine.
Dr. Cheungpasitporn specializes in acute kidney injury, chronic kidney disease, outpatient and home dialysis, hypertension, kidney stones, electrolyte disorders, and critical care nephrology. He is board-certified in internal medicine and nephrology by the American Board of Internal Medicine.
He earned his First-Class Honors medical degree from Chulalongkorn University in Thailand. Dr. Cheungpasitporn completed his internal medicine residency at Bassett Medical Center in New York, followed by fellowships in nephrology and kidney transplantation at Mayo Clinic in Minnesota. He also holds a postdoctoral diploma in Clinical and Translational Science from Mayo Clinic, with advanced training in epidemiology, clinical research, and statistical analysis. As a nephrologist and physician-scientist at Mayo Clinic, Dr. Cheungpasitporn is dedicated to transforming kidney care through innovation and evidence-based practice. His work focuses on integrating artificial intelligence (AI) and machine learning into nephrology to improve patient outcomes, accelerate research insights, and advance personalized medicine. His research interests include predictive modeling for acute kidney injury, AI-assisted decision support in dialysis and transplantation, and applications of health informatics in kidney care.
An internationally recognized researcher, Dr. Cheungpasitporn has authored numerous peer-reviewed articles, editorials, and reviews spanning clinical nephrology, kidney transplantation, and AI-driven innovations in kidney health. He has contributed to national nephrology guidelines and frequently presents on the intersection of technology and kidney health at leading national and international medical conferences.
In addition to his clinical and research work, Dr Cheungpasitporn serves as an active mentor to medical students, residents, and fellows in the United States and abroad. He serves on national and international committees, including the American Society of Nephrology’s Partnership for Responsible AI in Kidney Health. In 2025, he was selected as a Co-Lead for the “Thinking Outside the Box: Innovative Solutions and Future Directions” group at the KDIGO Controversies Conference on Technological Advancements to Support Guideline-Informed Care, contributing to forward-looking frameworks that support the responsible integration of emerging technologies in kidney care.
Allison
Dart
Allison Dart, MD, FRCPC
Associate Editor
Paediatrics
Dr. Dart is an Associate Professor in the Department of Pediatrics at the University of Manitoba. She is a Pediatric Nephrologist, and Clinician Researcher at the Children’s Hospital Research institute of Manitoba (CHRIM), and co-lead of the DREAM (Diabetes Research Envisioned and Accomplished in Manitoba) research team. Her research focuses on determinants of chronic kidney disease in children, with a special interest in improving outcomes in high-risk groups, including children living with type 2 diabetes and Indigenous populations. She is co-lead of the iCARE study, which is a national cohort study evaluating the biopsychosocial determinants of kidney disease in youth living with type 2 diabetes. She also has a special interest in patient engagement and patient reported outcome measures and is co-lead of the CanSOLVE CKD PRO-Kid study, a symptom assessment tool for children living with CKD.
Maoliosa
Donald
Maoliosa Donald, PhD
Associate Editor
Dr. Donald is an adjunct assistant professor in the Cumming School of Medicine (Division of Nephrology) at the University of Calgary and is an implementation consultant with The Center for Implementation. She is a health services researcher and physical therapist. Dr. Donald’s research interests include interventions that support person-centered care, and innovations that address the evidence-practice gap for patients with early chronic kidney disease.
Meghan
Elliott
Meghan Elliott, MD, MSc, FRCPC
Associate Editor
Qualitative Research/Mixed Methods (CKD, dialysis, POR)
Dr. Elliott is a clinician scientist with clinical training in nephrology and a research focus in chronic kidney disease care delivery. Dr. Elliott's program of research employs primarily qualitative and mixed methods to understand patients' needs and priorities, identify care gaps, and develop interventions that support self-management and integrated care in the community. Examples of projects related to this theme include the implementation of patient-reported outcome measures in hemodialysis care, shared decision-making in dialysis-related treatment decisions, and patient-centered models of urgent care delivery. Dr. Elliott engages with patients as partners throughout her research.
Janine
Farragher
Janine Farragher, PhD, OT Reg
Associate Editor
Qualitative Research/Mixed Methods (POR)
Dr. Farragher is an Assistant Professor in the Department of Occupational Science and Occupational Therapy at the University of Toronto. She is an occupational therapist and holds a Canada Research Chair (Tier 2) in Life Participation and Kidney Disease. Dr. Farragher’s research is focused on identifying holistic pathways to promote life participation in chronic kidney disease, with a particular interest in addressing cognitive, psychosocial and environmental factors that affect participation and engagement.
Gregory
Hundemer
Gregory Hundemer, MD, MPH, FRCPC
Associate Editor
Hypertension
Dr. Hundemer is a staff nephrologist at the Ottawa Hospital, an assistant professor of medicine with a cross-appointment in the School of Epidemiology and Public Health at the University of Ottawa, and an associate scientist at the Ottawa Hospital Research Institute. Dr. Hundemer completed his internal medicine and nephrology training at Massachusetts General Hospital and Brigham and Women's Hospital, Harvard Medical School. His research interests involve understanding the clinical implications of overt and subclinical forms of aldosterone excess and improving treatment approaches for these conditions. His research has been funded by the CIHR, NIH, Kidney Foundation of Canada, KRESCENT New Investigator Award, and Lorna Jocelyn Wood Chair in Kidney Research.
Ngan
Lam
Ngan Lam, MD, MSc, FRCPC
Associate Editor
Dr. Lam is a clinician scientist, transplant nephrologist and associate professor, Division of Nephrology at the University of Calgary. She completed her fellowships in nephrology and clinical kidney transplantation at Western University. Dr. Lam also completed her Master of Science in clinical epidemiology and biostatistics at Western University and is a graduate of the KRESCENT post-doctoral fellowship (2012-2015). She was awarded the KRESCENT new investigator award (2015-2018) to continue her research on the long-term outcomes of kidney transplant recipients and living kidney donors.
Caroline
Lamarche
Caroline Lamarche, MD, FRCPC
Associate Editor
Basic Science (immunology)
Transplantation, immunology
Dr. Lamarche is a transplant nephrologist and clinician-scientist at Hôpital Maisonneuve-Rosemont, and Associate Clinical Professor at the Université de Montréal. She completed her medical training and nephrology fellowship at Université de Montréal, followed by postdoctoral training in immunology at the University of British Columbia.
Dr. Lamarche’s research focuses on regulatory T cell (Treg) immunotherapy in kidney disease, with an emphasis on Treg dysfunction in hemodialysis and transplantation. She is supported by a salary award from the Fonds de recherche du Québec – Santé (FRQS).
Sara
Mahdavi
Sara Mahdavi, PhD
Editorial Board Member
Dr. Sara Mahdavi is a Research Fellow and International Scholar at Harvard T.H. Chan School of Public Health. She is an adjunct professor in the Department of Nutritional Sciences and a clinician scientist and research instructor in the Department of Community and Family Medicine at the University of Toronto. She is a clinical scientist and a nephrology renal dietician (RD) with specialized training in Gene-Nutrition interaction in young adults as well as chronic disease populations. She also holds a clinical instructor and research appointment with the Department of Community and Family Medicine at the University of Toronto and serves as a scientific advisor on several government, non-for-profit and for profit organizations.
Dr. Mahdavi received her doctorate from the Faculty of Medicine at the University of Toronto in the field of gene-environment interactions and cardiometabolic disease. She has been practicing clinical dietetics over the last decade at several Ontario hospitals as well as private practice. Dr. Mahdavi has been an invited speaker at several medical conferences and for government agencies. She has published over a dozen original peer-reviewed scientific articles in top medical journals, has been an invited reviewer for several clinical journals and has been serving on the editorial board of CJKHD since its inception in 2014.
Dr. Mahdavi’s clinical research and practice have varied from predictors of early insulin sensitivity and dietary patterns, complex disease genomics including gene-environment interaction on cardiovascular and diabetes susceptibility, kidney disease and related bone-mineral disorders, proteomics and metabolomics in early disease detection, rare genetic disorders such as Fabry disease, and innovative dermatological interventions including treatment of calciphylaxis.
Dr. Mahdavi is a Research Fellow and International Scholar at Harvard T.H. Chan School of Public Health, an adjunct professor in the Department of Nutritional Sciences and a clinician scientist and research instructor in the Department of Community and Family Medicine at the University of Toronto.
Thomas
Mavrakanas
Thomas Mavrakanas, MD, MSc, FRCPC
Associate Editor
Clinical trials
Dialysis (hemodialysis)
Non-dialysis nephrology (cardiorenal, CKD, diabetes)
Dr. Mavrakanas is a clinician scientist, nephrologist, and assistant professor at McGill University. His research has been focused on the causes of and treatments for cardiovascular disease in patients with chronic kidney disease and end-stage renal disease. Dr. Mavrakanas has 60 peer-reviewed publications and has received multiple competitive peer-reviewed grants or scholarships. Dr. Mavrakanas received his medical diploma and a Master of Science degree in medical research methodology from the Aristotle University in Thessaloniki, Greece, in 2001 and 2006, respectively. Having completed his specialty training in internal medicine in France and Switzerland between 2006 and 2011, he obtained an attending physician job at Geneva University Hospitals in Switzerland in 2012. After two years of subspecialty training in nephrology at McGill University, Dr. Mavrakanas did a research fellowship at Brigham & Women’s Hospital, Harvard Medical School. He then returned to Geneva University in 2017 and was promoted to the rank of Privat-Dozent (habilitation thesis) prior to joining McGill University Health Center in 2020.
Amber
Molnar
Amber Molnar, MD, MSc, FRCPC
Associate Editor
Dialysis (hemodialysis)
Non-dialysis nephrology (CKD)
Dr. Molnar is an associate professor with the Department of Medicine, Division of Nephrology at McMaster University and holds a cross appointment with the Department of Health Research Methods, Evidence and Impact. She received her MD at the University of Saskatchewan and completed Internal Medicine training at Western University. She then completed her Nephrology training followed by a two-year research fellowship and MSc in Epidemiology at the University of Ottawa. She is an adjunct scientist with ICES. In this role, she is able to use large, provincial healthcare databases to answer research questions pertinent to patients with kidney disease. Her research program focuses primarily on improving outcomes for patients with chronic kidney disease and on hemodialysis. She also serves as an associate editor for the Canadian Journal of Kidney Health and Disease, the official journal of the Canadian Society of Nephrology, and is the co-Lead on the Communications and Engagement for the Canadian Nephrology Trials Network.
Keigan
More
Keigan More, MD, MSc, FRPC
Associate Editor of Case Reports
Case reports
Dr. More is a nephrologist and assistant professor in the Department of Medicine at Dalhousie University. He received his MD at the University of British Columbia and completed Internal Medicine and Nephrology training at Dalhousie University. He completed a Master of Science in Quality Improvement and Patient Safety at the Institute of Health Policy, Management and Evaluation at the University of Toronto. He currently serves as the medical director of Renal Quality for the Nova Scotia Renal Program Central Zone and is program director of the Dalhousie University Adult Nephrology training program.
Ramesh
Prasad
Ramesh Prasad, MD, MSc, PhD, FRCPC
Associate Editor
Dr. Prasad is a nephrologist, professor of medicine at the University of Toronto, and director of the Kidney Transplant Program at St. Michael’s Hospital. Dr. Prasad obtained his medical degree from Osmania University, Hyderabad, India. He completed his internal medicine residency at Wayne State University / Detroit Medical Center, his nephrology fellowship at the University of Pittsburgh Medical Center, and a transplantation nephrology fellowship at Toronto General Hospital. Dr. Prasad holds a Master of Science degree in medical science from the University of Toronto and a PhD in philosophy. Dr. Prasad’s research interest includes all aspects pertinent to the long-term health of both kidney transplant recipients and donors, and the philosophy of science and medicine. He has published over 130 peer-reviewed articles. He is certified and recertified in both internal medicine and nephrology by the American Board of Internal Medicine and has a specialist certificate in hypertension from the American Society of Hypertension. He serves on the Declaration of Istanbul Custodian Group, Canadian Hypertension Education Program, and various committees of the Canadian and American Societies of Transplantation.
Claudio
Rigatto
Claudio Rigatto, MD, MSc, FRCPC
Associate Editor
Non-dialysis nephrology
Dr. Rigatto is an associate professor at the University of Manitoba Faculty of Medicine and an attending nephrologist at both St. Boniface and Seven Oaks General Hospitals. He received his medical training at the University of Manitoba, including a BSc. in Medicine and at Memorial University in Newfoundland where he received his MSc. in Medicine. Dr. Rigatto is a clinical epidemiologist and serves as chair of the Can-SOLVE CKD Network Research Operations Committee.
Dr. Rigatto’s research is focused on biomarkers as predictors of outcomes in both acute and chronic kidney disease. He is a lead investigator with the Winnipeg Cardiac Surgery Cohort, a prospective cohort study of renal outcomes after heart surgery, where his research focuses on intraoperative biomarkers of acute kidney injury. He is also one of the lead investigators for the CanPREDDICT Consortium, a prospective cohort of 2500 CKD patients followed by nephrologists across Canada exploring utility of newer markers of renal and vascular health in prediction of patient-important outcomes in CKD.
Marko
Škrtić
Marko Škrtić, MD, PhD, FRCPC
Associate Editor
Basic Science (AKI, immunology, onconephrology)
Dialysis (home dialysis, peritoneal dialysis)
Dr. Marko Škrtić was born in Karlovac, Croatia and spent his childhood years in Hamilton, Ontario. After undergraduate studies in Biology at McMaster University, he pursued the MD PhD program at the University of Toronto where he completed his PhD under the supervision of Dr. Aaron Schimmer studying mitochondrial biology in acute myeloid leukaemia. Afterwards, he completed internal medicine training at the University of Toronto, followed by nephrology residency at McMaster University.
He has completed clinical fellowships in Onco-Nephrology, General Nephrology, and Home Dialysis at the University Health Network/University of Toronto. Additionally, he completed a three-year research fellowship with Dr. Lisa Robinson studying macrophage cell biology at the Hospital for Sick Children as a part of the KRESCENT post-doctoral fellowship program.
His clinical interests include onco-nephrology, peritoneal dialysis and home hemodialysis. His research focus is on inflammatory modulation in kidney disease and dialysis.
Elena
Torban
Elena Torban, PhD
Associate Editor
Dr. Torban is an associate professor in the Department of Medicine, Division of Experimental Medicine at McGill Univeresity, and a basic scientist in the Division of Nephrology, McGill University Health Center. She received her PhD in kidney development at McGill and her post-doctoral training at the Montreal Neurological Institute and at McGill. Dr. Torban’s research focuses on pathomechanisms of glomerular disease, as well as the molecular and cellular mechanisms by which planar cell polarity signaling pathways regulate normal kidney development. Her research is funded by Kidney Foundation of Canada and the Canadian Institutes of Health Research.
VIEW CJKHD TOCs
2026: Jul | Jun | May | Apr | Mar | Feb | Jan
2025: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Feb | Jan
2024: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Mar | Feb | Jan
2023: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2022: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2021: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
